Authors' Reply to Kaplan Comment on “Safety and Efficacy of Oral Ferric Maltol and Ferrous Sulfate for Iron Deficiency Anemia in Infants, Children and Adolescents: A Multicenter Randomized Trial”
Pediatric Drugs · 2026-11 · 28 (6) · 737-738
DOI: 10.1007/s40272-026-00775-0 ↗Kurz gefasst
Leserbrief in der Zeitschrift Pediatric Drugs, online erschienen am 18.09.2026. Verfasst von Richard K Russell. Beteiligte Einrichtung: NHS Scotland, Edinburgh, UK. richard.russell@nhs.scot. Die Arbeit nennt 5 Literaturangaben.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- NHS Scotland, Edinburgh, UK. richard.russell@nhs.scot.
- Department of Paediatric Gastroenterology, Royal Hospital for Children and Young People, Clinical Staff Offices, 2nd Floor, 50 Little France Crescent, Edinburgh, EH16 4TJ, UK. richard.russell@nhs.scot.
Zitieren
APA
Russell, R. K. (2026). Authors' Reply to Kaplan Comment on “Safety and Efficacy of Oral Ferric Maltol and Ferrous Sulfate for Iron Deficiency Anemia in Infants, Children and Adolescents: A Multicenter Randomized Trial”. Pediatric Drugs, 28(6), 737-738. https://doi.org/10.1007/s40272-026-00775-0
Vancouver
Russell RK. Authors' Reply to Kaplan Comment on “Safety and Efficacy of Oral Ferric Maltol and Ferrous Sulfate for Iron Deficiency Anemia in Infants, Children and Adolescents: A Multicenter Randomized Trial”. Pediatric Drugs. 2026;28(6):737-738. doi:10.1007/s40272-026-00775-0
BibTeX
@article{Russell2026,
author = {Russell, Richard K},
title = {Authors' Reply to Kaplan Comment on “Safety and Efficacy of Oral Ferric Maltol and Ferrous Sulfate for Iron Deficiency Anemia in Infants, Children and Adolescents: A Multicenter Randomized Trial”},
journal = {Pediatric Drugs},
year = {2026},
volume = {28},
number = {6},
pages = {737--738},
doi = {10.1007/s40272-026-00775-0}
}
EUVIMED